HCC Innervation Assessment

Launched by HOSPICES CIVILS DE LYON · Mar 14, 2025

Keywords

ClinConnect Summary

This clinical trial, called HCC Innervation Assessment, is focused on studying how nerve connections in and around tumors affect patients with hepatocellular carcinoma (HCC), a type of primary liver cancer. The goal is to better understand these nerve connections in patients who are undergoing surgery to remove their liver tumors or who are receiving liver transplants. By examining these nerves, researchers hope to find new ways to classify and treat HCC, which can vary greatly from one patient to another.

To participate in this trial, you must be an adult with HCC who is having surgery or a transplant, regardless of whether you have received treatment before. Unfortunately, pregnant or breastfeeding women, minors, and individuals under legal protection cannot join. If you take part in this study, you can expect to provide information about your health and undergo assessments related to the nerve connections in your liver. The findings from this research may help improve treatment options for HCC in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with hepatocarcinoma who undergo surgical resection or liver transplant
• • Patients with and without treatment
• Exclusion Criteria:
• • - Pregnant or lactating women
• • Minor patient
• • Patient under legal protection measure or deprived of their liberty